Cargando…

Are Serum Levels of Nuclear Factor Kappa B and Forkhead Box Protein P3 in Patients with Non-Alcoholic Fatty Liver Disease Related to Severity of Fibrosis?

BACKGROUND Inflammation has a significant impact on the development and progression of fatty liver diseases.In this study, we aimed to investigate the relation between serum levels of nuclear factor kappa B (NFkB) and Forkhead box protein P3 (FOXP3)with fibrosis severity among patients with non-alco...

Descripción completa

Detalles Bibliográficos
Autores principales: Sohrabi, Masoudreza, Gholami, Ali, Amir Kalali, Bahareh, Khoonsari, Mahmoodreza, Sahraei, Roghieh, Nasiri Toosi, Mohsen, Zamani, Farhad, Keyvani, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Association of Gastroerterology and Hepatology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489454/
https://www.ncbi.nlm.nih.gov/pubmed/36606010
http://dx.doi.org/10.34172/mejdd.2021.247
_version_ 1784792885949890560
author Sohrabi, Masoudreza
Gholami, Ali
Amir Kalali, Bahareh
Khoonsari, Mahmoodreza
Sahraei, Roghieh
Nasiri Toosi, Mohsen
Zamani, Farhad
Keyvani, Hossein
author_facet Sohrabi, Masoudreza
Gholami, Ali
Amir Kalali, Bahareh
Khoonsari, Mahmoodreza
Sahraei, Roghieh
Nasiri Toosi, Mohsen
Zamani, Farhad
Keyvani, Hossein
author_sort Sohrabi, Masoudreza
collection PubMed
description BACKGROUND Inflammation has a significant impact on the development and progression of fatty liver diseases.In this study, we aimed to investigate the relation between serum levels of nuclear factor kappa B (NFkB) and Forkhead box protein P3 (FOXP3)with fibrosis severity among patients with non-alcoholic fatty liver disease(NAFLD). METHODS In a prospective study, the patients suspicios of havingfatty liver were enrolled. The exclusion criteria lack of viral hepatitis, autoimmune hepatitis, Wilson’s or other known liver diseases,history of liver or biliary surgery,bariatric surgery, and medications that influence liver metabolism. The participantsunderwent liver fibroscan. According to liver fibrosis, the patients weredivided into two groups; 1)fibrosis less than 7.2 KP,2)advanced NAFLD, fibrosis ≥7.3 KP. A10 cc fasting blood sample was taken from each patient for laboratory assessments.The variables between the two groups were compared using Chi-square or Fisher’s exact test.The independence of cytokines was assessed by a logistic regression test. RESULTS Totally 90 patients were enrolled.The mean age was 42.21 ± 11 years. Of them, 50 and 47 participants were allocated to groups 1 and 2, respectively. In the univariate analysis, we revealed asignificant difference between age, body mass index (BMI), fasting blood glucose, liver enzymes, total cholesterol, andtriglyceride levels. Also, there was a significant difference betweenthe levels of NFKB and FOXP3 in group one compared with group two of the participants,as FOXP3(9.17 ± 10.0 vs. 18.63 ± 12.9; p < 0.001) and NFKB (1.70 ± 1.70; p < 0.01). After excluding the confounding factors, we observed a significant association between fibrosis level and cytokine levels in logistic regression. CONCLUSION Serum levels of NFKB and FOXP3 increased by advancing liver fibrosis in patients with NAFLD.This is an independent association. The identification of intermediary regulatory factors would be necessary.
format Online
Article
Text
id pubmed-9489454
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Iranian Association of Gastroerterology and Hepatology
record_format MEDLINE/PubMed
spelling pubmed-94894542023-01-04 Are Serum Levels of Nuclear Factor Kappa B and Forkhead Box Protein P3 in Patients with Non-Alcoholic Fatty Liver Disease Related to Severity of Fibrosis? Sohrabi, Masoudreza Gholami, Ali Amir Kalali, Bahareh Khoonsari, Mahmoodreza Sahraei, Roghieh Nasiri Toosi, Mohsen Zamani, Farhad Keyvani, Hossein Middle East J Dig Dis Original Article BACKGROUND Inflammation has a significant impact on the development and progression of fatty liver diseases.In this study, we aimed to investigate the relation between serum levels of nuclear factor kappa B (NFkB) and Forkhead box protein P3 (FOXP3)with fibrosis severity among patients with non-alcoholic fatty liver disease(NAFLD). METHODS In a prospective study, the patients suspicios of havingfatty liver were enrolled. The exclusion criteria lack of viral hepatitis, autoimmune hepatitis, Wilson’s or other known liver diseases,history of liver or biliary surgery,bariatric surgery, and medications that influence liver metabolism. The participantsunderwent liver fibroscan. According to liver fibrosis, the patients weredivided into two groups; 1)fibrosis less than 7.2 KP,2)advanced NAFLD, fibrosis ≥7.3 KP. A10 cc fasting blood sample was taken from each patient for laboratory assessments.The variables between the two groups were compared using Chi-square or Fisher’s exact test.The independence of cytokines was assessed by a logistic regression test. RESULTS Totally 90 patients were enrolled.The mean age was 42.21 ± 11 years. Of them, 50 and 47 participants were allocated to groups 1 and 2, respectively. In the univariate analysis, we revealed asignificant difference between age, body mass index (BMI), fasting blood glucose, liver enzymes, total cholesterol, andtriglyceride levels. Also, there was a significant difference betweenthe levels of NFKB and FOXP3 in group one compared with group two of the participants,as FOXP3(9.17 ± 10.0 vs. 18.63 ± 12.9; p < 0.001) and NFKB (1.70 ± 1.70; p < 0.01). After excluding the confounding factors, we observed a significant association between fibrosis level and cytokine levels in logistic regression. CONCLUSION Serum levels of NFKB and FOXP3 increased by advancing liver fibrosis in patients with NAFLD.This is an independent association. The identification of intermediary regulatory factors would be necessary. Iranian Association of Gastroerterology and Hepatology 2021-10 2022-01-27 /pmc/articles/PMC9489454/ /pubmed/36606010 http://dx.doi.org/10.34172/mejdd.2021.247 Text en © 2021 The Author(s). https://creativecommons.org/licenses/by-nc/4.0/ This work is published by Middle East Journal of Digestive Diseases as an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Original Article
Sohrabi, Masoudreza
Gholami, Ali
Amir Kalali, Bahareh
Khoonsari, Mahmoodreza
Sahraei, Roghieh
Nasiri Toosi, Mohsen
Zamani, Farhad
Keyvani, Hossein
Are Serum Levels of Nuclear Factor Kappa B and Forkhead Box Protein P3 in Patients with Non-Alcoholic Fatty Liver Disease Related to Severity of Fibrosis?
title Are Serum Levels of Nuclear Factor Kappa B and Forkhead Box Protein P3 in Patients with Non-Alcoholic Fatty Liver Disease Related to Severity of Fibrosis?
title_full Are Serum Levels of Nuclear Factor Kappa B and Forkhead Box Protein P3 in Patients with Non-Alcoholic Fatty Liver Disease Related to Severity of Fibrosis?
title_fullStr Are Serum Levels of Nuclear Factor Kappa B and Forkhead Box Protein P3 in Patients with Non-Alcoholic Fatty Liver Disease Related to Severity of Fibrosis?
title_full_unstemmed Are Serum Levels of Nuclear Factor Kappa B and Forkhead Box Protein P3 in Patients with Non-Alcoholic Fatty Liver Disease Related to Severity of Fibrosis?
title_short Are Serum Levels of Nuclear Factor Kappa B and Forkhead Box Protein P3 in Patients with Non-Alcoholic Fatty Liver Disease Related to Severity of Fibrosis?
title_sort are serum levels of nuclear factor kappa b and forkhead box protein p3 in patients with non-alcoholic fatty liver disease related to severity of fibrosis?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489454/
https://www.ncbi.nlm.nih.gov/pubmed/36606010
http://dx.doi.org/10.34172/mejdd.2021.247
work_keys_str_mv AT sohrabimasoudreza areserumlevelsofnuclearfactorkappabandforkheadboxproteinp3inpatientswithnonalcoholicfattyliverdiseaserelatedtoseverityoffibrosis
AT gholamiali areserumlevelsofnuclearfactorkappabandforkheadboxproteinp3inpatientswithnonalcoholicfattyliverdiseaserelatedtoseverityoffibrosis
AT amirkalalibahareh areserumlevelsofnuclearfactorkappabandforkheadboxproteinp3inpatientswithnonalcoholicfattyliverdiseaserelatedtoseverityoffibrosis
AT khoonsarimahmoodreza areserumlevelsofnuclearfactorkappabandforkheadboxproteinp3inpatientswithnonalcoholicfattyliverdiseaserelatedtoseverityoffibrosis
AT sahraeiroghieh areserumlevelsofnuclearfactorkappabandforkheadboxproteinp3inpatientswithnonalcoholicfattyliverdiseaserelatedtoseverityoffibrosis
AT nasiritoosimohsen areserumlevelsofnuclearfactorkappabandforkheadboxproteinp3inpatientswithnonalcoholicfattyliverdiseaserelatedtoseverityoffibrosis
AT zamanifarhad areserumlevelsofnuclearfactorkappabandforkheadboxproteinp3inpatientswithnonalcoholicfattyliverdiseaserelatedtoseverityoffibrosis
AT keyvanihossein areserumlevelsofnuclearfactorkappabandforkheadboxproteinp3inpatientswithnonalcoholicfattyliverdiseaserelatedtoseverityoffibrosis